Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q1 2025 Earnings Call Transcript May 9, 2025 Rapid Micro Biosystems, Inc. beats ...

Q1 2025 Earnings Call Transcript May 8, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.42 EPS, ...

Cummins Inc. shareholders will consider a proposal to split the chairman and chief executive officer roles during the company ...

OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC) ("ContextLogic,” the "Company,” "we” or "our”) today reported its financial results for the quarter ended March 31, ...

General and Administrative (G&A) Expenses. G&A expenses for the three months ended March 31, 2025 were $6.9 million compared to $5.1 million for the same period in 2024. The increase was primarily ...

The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of option and ...

Research and Development (R&D) Expenses: R&D expenses for the three months ended March 31, 2025, were $4.4 million, compared to $15.8 million for the same period in 2024. The decrease was due ...

Welcome to the Amprius Technologies First Quarter 2025 Earnings Conference Call. Joining us for today's presentation are the Company's CEO, Dr. Kang Sun; and CFO, Sandra Wallach. At this time, all ...

Net revenue for the third quarter of fiscal 2025 was $266.6 million. GAAP net loss for the third quarter of fiscal 2025 was $21.8 million, or a loss of $0.56 per basic share. Non-GAAP net income for ...

Sensata Technologies (NYSE: ST) today announced financial results for its first quarter ended March 31, 2025. "We started the ...

ALLY Robotic Laser Cataract Systems ("ALLY Systems") placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025 34% Revenue growth over the first ...